Crossref journal-article
Public Library of Science (PLoS)
PLoS ONE (340)
Bibliography

Scholefield, J., Greenberg, L. J., Weinberg, M. S., Arbuthnot, P. B., Abdelgany, A., & Wood, M. J. A. (2009). Design of RNAi Hairpins for Mutation-Specific Silencing of Ataxin-7 and Correction of a SCA7 Phenotype. PLoS ONE, 4(9), e7232.

Authors 6
  1. Janine Scholefield (first)
  2. L. Jacquie Greenberg (additional)
  3. Marc S. Weinberg (additional)
  4. Patrick B. Arbuthnot (additional)
  5. Amr Abdelgany (additional)
  6. Matthew J. A. Wood (additional)
References 50 Referenced 49
  1. 10.1007/BF00310370 / Acta Neuropathol / On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. by JJ Martin (1994)
  2. 10.1038/ng0997-65 / Nat Genet / Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. by G David (1997)
  3. 10.1016/S0022-510X(03)00209-0 / J Neurol Sci / The hereditary adult-onset ataxias in South Africa. by A Bryer (2003)
  4. 10.1038/nm1298 / Nat Med / 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. by M Waza (2005)
  5. 10.1523/JNEUROSCI.5453-06.2007 / J Neurosci / A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes. by M Latouche (2007)
  6. 10.1093/hmg/ddm213 / Hum Mol Genet 16 Spec / Polyglutamine diseases: emerging concepts in pathogenesis and therapy. by J Shao (2007)
  7. 10.1093/hmg/ddl148 / Hum Mol Genet / Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. by PS Thomas (2006)
  8. 10.1093/hmg/ddi147 / Hum Mol Genet / Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. by JM Van Raamsdonk (2005)
  9. 10.1007/s12311-008-0027-y / Cerebellum / Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration. by GA Garden (2008)
  10. 10.1371/journal.pone.0003341 / PLoS ONE / Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease. by S Alves (2008)
  11. 10.1038/nm1076 / Nat Med / RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. by H Xia (2004)
  12. 10.1073/pnas.0501507102 / Proc Natl Acad Sci USA / RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. by SQ Harper (2005)
  13. 10.1093/hmg/ddg280 / Hum Mol Genet / Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. by A Abdelgany (2003)
  14. 10.1073/pnas.1231012100 / Proc Natl Acad Sci USA / Allele-specific silencing of dominant disease genes. by VM Miller (2003)
  15. 10.1101/gad.862301 / Genes Dev / RNA interference is mediated by 21- and 22-nucleotide RNAs. by SM Elbashir (2001)
  16. 10.1038/nsmb780 / Nat Struct Mol Biol / Kinetic analysis of the RNAi enzyme complex. by B Haley (2004)
  17. 10.1371/journal.pgen.0020140 / PLoS Genet / Designing siRNA that distinguish between genes that differ by a single nucleotide. by DS Schwarz (2006)
  18. 10.1046/j.1474-9728.2003.00054.x / Aging Cell / Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. by H Ding (2003)
  19. 10.1093/nar/gki312 / Nucleic Acids Res / A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. by Q Du (2005)
  20. 10.1073/pnas.0601309103 / Proc Natl Acad Sci USA / Determinants of specific RNA interference-mediated silencing of human beta-globin alleles differing by a single nucleotide polymorphism. by DM Dykxhoorn (2006)
  21. 10.1093/nar/gkh208 / Nucleic Acids Res / Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. by VM Miller (2004)
  22. 10.1016/j.gene.2005.11.006 / Gene / Allele-specific silencing of Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations. by X Feng (2006)
  23. 10.1016/j.nbd.2006.04.019 / Neurobiol Dis / Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo. by X Xia (2006)
  24. 10.1038/nbt.1539 / Nat Biotechnol / Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. by J Hu (2009)
  25. 10.1093/hmg/11.2.175 / Hum Mol Genet / Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. by NJ Caplen (2002)
  26. 10.1111/j.1399-0004.2006.00680.x / Clin Genet / Origin of the SCA7 gene mutation in South Africa: implications for molecular diagnostics. by J Greenberg (2006)
  27. 10.1083/jcb.200511045 / J Cell Biol / PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. by A Janer (2006)
  28. 10.1093/hmg/10.22.2569 / Hum Mol Genet / Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3. by C Zander (2001)
  29. 10.1261/rna.1062908 / RNA / Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. by RL Boudreau (2008)
  30. 10.1038/nature04791 / Nature / Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. by D Grimm (2006)
  31. 10.1073/pnas.0801775105 / Proc Natl Acad Sci USA / Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. by JL McBride (2008)
  32. 10.1038/mt.2008.82 / Mol Ther / Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. by A Ely (2008)
  33. 10.1038/mt.2008.231 / Mol Ther / Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. by RL Boudreau (2009)
  34. 10.1128/MCB.01248-06 / Mol Cell Biol / Specific isoforms of translation initiation factor 4GI show differences in translational activity. by MJ Coldwell (2006)
  35. 10.1371/journal.pone.0002248 / PLoS ONE / Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. by Y Ohnishi (2008)
  36. 10.1016/S0092-8674(03)00801-8 / Cell / Functional siRNAs and miRNAs exhibit strand bias. by A Khvorova (2003)
  37. 10.1016/S0092-8674(03)00759-1 / Cell / Asymmetry in the assembly of the RNAi enzyme complex. by DS Schwarz (2003)
  38. 10.1261/rna.546207 / RNA / Effect of target secondary structure on RNAi efficiency. by Y Shao (2007)
  39. 10.1038/mt.2008.144 / Mol Ther / Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic. by JC Giering (2008)
  40. 10.1038/nature02998 / Nature / Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. by M Arrasate (2004)
  41. 10.1038/sj.embor.7400250 / EMBO Rep / Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. by C Landles (2004)
  42. 10.1093/hmg/ddh139 / Hum Mol Genet / Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. by D Helmlinger (2004)
  43. 10.1016/S0896-6273(01)00422-6 / Neuron / Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. by AR La Spada (2001)
  44. 10.1073/pnas.0503505102 / Proc Natl Acad Sci USA / Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. by VB Palhan (2005)
  45. 10.1038/mt.2009.17 / Mol Ther / Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. by RL Boudreau (2009)
  46. 10.1002/ana.21569 / Ann Neurol / Sustained effects of nonallele-specific Huntingtin silencing. by V Drouet (2009)
  47. 10.1017/S1355838202021362 / RNA / Functional siRNA expression from transfected PCR products. by D Castanotto (2002)
  48. 10.1073/pnas.082243699 / Proc Natl Acad Sci USA / A monomeric red fluorescent protein. by RE Campbell (2002)
  49. 10.1261/rna.2299306 / RNA / Artificial control of gene expression in mammalian cells by modulating RNA interference through aptamer-small molecule interaction. by C An (2006)
  50. 10.1093/hmg/8.5.731 / Hum Mol Genet / Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. by DL Stenoien (1999)
Dates
Type When
Created 15 years, 11 months ago (Sept. 29, 2009, 1:48 p.m.)
Deposited 6 years, 10 months ago (Oct. 23, 2018, 2:12 p.m.)
Indexed 3 months ago (May 28, 2025, 1:23 p.m.)
Issued 15 years, 10 months ago (Sept. 30, 2009)
Published 15 years, 10 months ago (Sept. 30, 2009)
Published Online 15 years, 10 months ago (Sept. 30, 2009)
Funders 0

None

@article{Scholefield_2009, title={Design of RNAi Hairpins for Mutation-Specific Silencing of Ataxin-7 and Correction of a SCA7 Phenotype}, volume={4}, ISSN={1932-6203}, url={http://dx.doi.org/10.1371/journal.pone.0007232}, DOI={10.1371/journal.pone.0007232}, number={9}, journal={PLoS ONE}, publisher={Public Library of Science (PLoS)}, author={Scholefield, Janine and Greenberg, L. Jacquie and Weinberg, Marc S. and Arbuthnot, Patrick B. and Abdelgany, Amr and Wood, Matthew J. A.}, editor={Cookson, Mark R.}, year={2009}, month=sep, pages={e7232} }